p53, the Cellular Gatekeeper for Growth and Division
暂无分享,去创建一个
[1] A. Levine,et al. Identification of a novel p53 functional domain that is necessary for efficient growth suppression. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[2] A. Levine,et al. Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain , 1996, Science.
[3] C. Prives,et al. A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis , 1996, Molecular and cellular biology.
[4] J. Danska,et al. V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors. , 1996, Genes & development.
[5] 野元 諭,et al. 催奇性障害防御におけるp53 dependent apoptosisの役割 , 1996 .
[6] K. Kinzler,et al. Genetic determinants of p53-induced apoptosis and growth arrest. , 1996, Genes & development.
[7] Å. Borg,et al. A novel p53 germline alteration identified in a late onset breast cancer kindred. , 1996, Oncogene.
[8] T. Aas,et al. Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients , 1996, Nature Medicine.
[9] A. Levine,et al. A functionally inactive p53 protein interatocarcinoma cells is activated by either DNA damage or cellular differentiation , 1996, Nature Medicine.
[10] C. Prives,et al. p53: puzzle and paradigm. , 1996, Genes & development.
[11] G. Wahl,et al. A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. , 1996, Genes & development.
[12] G. Woude,et al. Abnormal Centrosome Amplification in the Absence of p53 , 1996, Science.
[13] David E. Housman,et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours , 1996, Nature.
[14] A. Levine,et al. Gas1-induced growth suppression requires a transactivation-independent p53 function , 1995, Molecular and cellular biology.
[15] Guillermina Lozano,et al. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53 , 1995, Nature.
[16] S. Velasco-Miguel,et al. Induction of the growth inhibitor IGF-binding protein 3 by p53 , 1995, Nature.
[17] D. Haber,et al. The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis. , 1995, Genes & development.
[18] A. Levine,et al. Essential role for p53-mediated transcription in E1A-induced apoptosis. , 1995, Genes & development.
[19] E. Shaulian,et al. Induction of apoptosis in HeLa cells by trans-activation-deficient p53. , 1995, Genes & development.
[20] Stephen J. Elledge,et al. Mice Lacking p21 CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control , 1995, Cell.
[21] T. Hambuch,et al. p53 dependent growth suppression by the c-Abl nuclear tyrosine kinase. , 1995, Oncogene.
[22] A. Levine,et al. p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches , 1995, Cell.
[23] C. Prives,et al. Activation of p53 sequence-specific DNA bindingby short single strands of DNA requires the p53 C-terminus , 1995, Cell.
[24] P. G. Wells,et al. A teratologic suppressor role for p53 in benzo(a)pyrene–treated transgenic p53-deficient mice , 1995, Nature Genetics.
[25] J. R. Smith,et al. Mutant p53 rescues human diploid cells from senescence without inhibiting the induction of SDI1/WAF1. , 1995, Cancer research.
[26] A. Levine,et al. Human TAFII31 protein is a transcriptional coactivator of the p53 protein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[27] D. Pinkel,et al. Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability. , 1995, Genes & development.
[28] N. Pavletich,et al. Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms , 1995, Science.
[29] Carissa A. Sanchez,et al. A p53-dependent mouse spindle checkpoint , 1995, Science.
[30] R. Tjian,et al. p53 transcriptional activation mediated by coactivators TAFII40 and TAFII60. , 1995, Science.
[31] John Calvin Reed,et al. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene , 1995, Cell.
[32] M. Evans,et al. p53 modulation of TFIIH–associated nucleotide excision repair activity , 1995, Nature Genetics.
[33] N. Hay,et al. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1. , 1994, Genes & development.
[34] D. Lane,et al. Allosteric activation of latent p53 tetramers , 1994, Current Biology.
[35] R Montesano,et al. Database of p53 gene somatic mutations in human tumors and cell lines. , 1994, Nucleic acids research.
[36] S. Lowe,et al. p53-Dependent apoptosis suppresses tumor growth and progression in vivo , 1994, Cell.
[37] T. Jacks,et al. Cooperative tumorigenic effects of germline mutations in Rb and p53 , 1994, Nature Genetics.
[38] M. Karin,et al. p53-Dependent apoptosis in the absence of transcriptional activation of p53-target genes , 1994, Nature.
[39] P. Jeffrey,et al. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. , 1994, Science.
[40] E. White,et al. Both viral (adenovirus E1B) and cellular (hsp 70, p53) components interact with centrosomes , 1994, Journal of cellular physiology.
[41] D. Albert,et al. Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53. , 1994, Genes & development.
[42] A. Levine,et al. p53 and E2F-1 cooperate to mediate apoptosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[43] A. Levine,et al. Functions of the p53 protein in growth regulation and tumor suppression. , 1994, Cold Spring Harbor symposia on quantitative biology.
[44] T. Jacks,et al. Sunburn and p53 in the onset of skin cancer , 1994, Nature.
[45] J. Trent,et al. WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.
[46] D. Housman,et al. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents , 1993, Cell.
[47] L. Donehower,et al. Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors , 1993, Cell.
[48] A. Levine,et al. Gain of function mutations in p53 , 1993, Nature Genetics.
[49] Scott W. Lowe,et al. p53 is required for radiation-induced apoptosis in mouse thymocytes , 1993, Nature.
[50] E. White,et al. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. , 1993, Genes & development.
[51] S. Benchimol,et al. Growth suppression of Friend virus-transformed erythroleukemia cells by p53 protein is accompanied by hemoglobin production and is sensitive to erythropoietin , 1993, Molecular and cellular biology.
[52] B. Vogelstein,et al. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia , 1992, Cell.
[53] Thea D. Tlsty,et al. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53 , 1992, Cell.
[54] P. Meltzer,et al. Amplification of a gene encoding a p53-associated protein in human sarcomas , 1992, Nature.
[55] L. Donehower,et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours , 1992, Nature.
[56] A. Kimchi,et al. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6 , 1991, Nature.
[57] W. Wooster,et al. Crystal structure of , 2005 .